facebook Will we see legislation addressing rising drug prices this year? Probably not

BIG PHARMA POLITICS: Consumers pressure politicians to do something about rising drug prices. Read More

Will we see legislation addressing rising drug prices this year? Probably not

An Open Letter to Congress: Consumers demand lower prescription pricesRising drug prices have motivated Americans to pressure their elected officials for a fix. We have yet to see the federal government put meaningful protections in place, and a recent effort by Sen. Chuck Grassley, R-Iowa, fell apart entirely.

Grassley, chairman of the Senate Finance Committee, introduced the Prescription Drug Price Reduction Act with co-sponsor Sen. Ron Wyden, D-Ore. The measure would lower out-of-pocket prescription costs for seniors, capping them at $3,100 annually, require transparency and accountability for drug pricing, and save Medicare more than $100 billion over 10 years.

However, partisan finger-pointing has possibly ended efforts to pass the bill, and one of the only options for meaningful reform before the end of the year.

Politico reports that Grassley claims Democrats “left the negotiating table,”, while co-sponsor Wyden says Republicans never really supported it. Momentum for the measure stalled long ago amid GOP concerns, according to the article.

Both accuse each other’s parties of playing political games with prescription drug prices.

Do you think politics should get in the way of lowering costly prescription drug prices? Share your concerns with Voices for Affordable Health.